Absci Corporation (NASDAQ:ABSI) saw its shares drop 7.4% after the AI-driven drug discovery company reported fourth quarter revenue that missed analyst expectations. The company posted revenue of $0.7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback